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Figure 2. Gene expression (A-D) and protein synthesis (E, F) of calvarial os-
teoblasts subjected to compressive loading. (**p<0.01, *p<0.05).
no signiﬁcant changes of these molecules were observed at
strain of 20%.
Conclusions: The ﬁndings demonstrate that calvarial os-
teoblasts in 3-D constructs exhibit a considerable growth and
matrix production. The osteoblasts in polymer matrix constructs
are mechanoresponsive and can elicit magnitude-dependent cell
responses. Mechanostimulation of the cells in constructs showed
that at low/physiological levels, these signals are osteogenic.
However, the induction of osteogenic signals is inhibited at
higher magnitudes of compression. The results of this study
demonstrate the osteogenic potential of appropriate biomechan-
ical stimulation in bone formation.
Acknowledgements: This study was supported by NIH grants #
HD040939 and AR048781.
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INFLUENCE OF GROWTH FACTORS AND MATRIX
METALLOPROTEASES ON BONE FORMATION AND
TURNOVER IN ASEPTIC OSTEONECROSIS OF THE
FEMORAL HEAD
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M. Vogel1, J. Grifka1, S. Grässel1
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Purpose: Osteonecrosis of the femoral head (ONFH) usually af-
fects young individuals and has major impact on their individual
lifestyle. The pathogenetic mechanisms of ONFH and its bone
metabolism are unresolved up to date and no effective treat-
ment exists for improving repair of the damaged bone matrix.
Furthermore, arthroplasties in ONFH are associated with higher
failure rates compared to primary osteoarthritis (OA). Bone ma-
trix contains various growth factors and proteases which control
the processes of bone formation and resorption thereby playing
an important role not only in growth and development of bone
but also during repair in adults. We hypothesise that ONFH is as-
sociated with an altered expression and activity of growth factors
and metalloproteases (MMPs) and their endogenous inhibitors
(TIMPs) in the femoral head and neck which will inﬂuence molec-
ular composition and turnover rates of bone matrix and trabecular
bone structure.
Methods: The aim of this study was to investigate the gene
expression proﬁle of bone growth factors as TGFß1, BMP-2,
and BMP-7 in samples of patients with ONFH compared to OA.
Additionally, gene expression rates of matrix metalloproteases
MMP-2, MMP-9 and their endogenous inhibitors, TIMP-1 and
TIMP-2 were assessed using quantitative RT-PCR. Gelatine zy-
mography and reverse zymography display activity status and
secretion proﬁle of MMPs and TIMPs. In parallel, structural pa-
rameters of the bone matrix were evaluated by µCT.
Results: Our results demonstrate that gene expression rates of
BMP-2, BMP-7 and MMP-2, MMP-9 and TIMP-1 are signiﬁcantly
higher in patients with ONFH than in the control group, consisting
of primary osteoarthritis (OA) patients, while TIMP-2 gene ex-
pression is not altered. The structural appearance of the trabecu-
lar bone and its metrical parameters are altered in osteonecrotic
femoral head and neck. We have observed a signiﬁcantly de-
creased bone volume, connectivity density and structural model
index in patients with ONFH compared to OA. Preliminary results
demonstrate a MMP proﬁle shift towards production of active and
pro- MMP-2 in ONFH bone lysates while MMP-9 proﬁle seems
to remain unaltered compared to OA samples.
Conclusions: In conclusion, in patients with ONFH, bone
metabolism, turnover rate and structure is altered in the femoral
head and neck possibly resulting from a frustrated attempt to re-
place damaged extracellular matrix. Our ﬁndings help to improve
understanding of the bone metabolism in ONFH and help to ex-
plain the higher failure rates of arthroplasties in ONFH compared
to OA.
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MORPHOLOGY AND DEVELOPMENT OF FOCAL
REGIONS OF SUBCHONDRAL BONE RESORPTION IN
OSTEOARTHRITIS
C. Dixon, M. Foster, S. Jackson
AstraZeneca R&D Charnwood, Leicestershire, United Kingdom
Purpose: The presence of subchondral bone pits which con-
tain vascular, mesenchymal and osteoclast like cells have been
described in osteoarthritis (OA); however the role that these
pits may play in the aetiology and pathogenesis of the disease
process is unclear. These pits have been termed subchon-
dral bone resorption pits as they sit within the subchondral
plate and demonstrate active resorption of surrounding bone
and calciﬁed cartilage. Whilst these pits are present in normal
subchondral bone samples, where they probably relate to en-
dochondral ossiﬁcation, they are generally located beneath the
tide mark. In OA the number of resorption pits invading through
the tidemark is increased, with associated loss of matrix pro-
teoglycans. The mechanisms through which subchondral bone
resorption pits arise and their morphological development are
poorly understood. The purpose of this study was to investigate
the morphological characteristics, growth and development of
these subchondral bone resorption pits. We hypothesise that
these pits may arise from pre-existing vascular channels within
the subchondral bone
Methods: Osteoarthritic human femoral heads, representing a
range of OA disease severity from focal cartilage loss to loss
of deep zone cartilage, were obtained from patients undergoing
joint replacement. (n = 9, 4 female and 5 male, age range 57
to 82 years with median = 73 years). Tissue specimens con-
taining cartilage, underlying subchondral and trabecular bone
were resected from the femoral head, and embedded in parafﬁn
wax. 4µm serial sections were cut from each block to a depth
Osteoarthritis and Cartilage Vol. 15, Supplement C C87
of up to 112µm. Histological features of the subchondral bone
resorption pits were analysed with H&E staining. Tartrate resis-
tant acid phosphatase (TRAP) positive cells were identiﬁed by
immunohistochemsitry. Normal cartilage and subchondral bone
were obtained from femoral heads at post mortem from cadavers
with no clinical history of OA (n = 9).
Results: Resorption pits were divided into ﬁve groups which
were classiﬁed by morphological phenotype based on the con-
tent of cells present within the pit and the location of the pit within
the subchondral/calciﬁed cartilage space. All resorption pits ex-
amined contained TRAP positive osteoclast-like cells indicating
the destructive nature of these lesions. The concurrent presence
of osteoblasts and osteoclasts within the resorption pits suggests
the involvement of the resorption pits in the process of bone
remodelling and possibly sclerosis. Histological analysis of sam-
ples suggested that resorption pits may arise from the normal
pit structure that is seen within the subchondral plate and may
extend through a process of bone resorption and remodelling,
to involve a larger area of the subchondral region and encroach
on overlying calciﬁed and articular cartilage. 3D reconstruction
of subchondral bone resorption pits demonstrated a branching
morphology with smaller pits interlinking with a larger resorption
pit which linked with bone marrow. This branching morphology
suggesting possible development of resorption pits through pre-
existing vascular channels or the interaction of bridging areas of
bone resorption.
Conclusions: Subchondral bone resorption pits can be classi-
ﬁed into various types based on their morphology; these separate
classiﬁcations may represent a development sequence from fo-
cal (normal) areas of endochondral ossiﬁcation or expansion of
bone vascular channels. The extensive nature of these lesions
may also be a reﬂection of altered biomechanical stresses on the
subchondral plate and may, in turn, contribute to altered bone
responses and joint instability in OA.
Cartilage /Chondrocyte Biology
142
ALK1 OPPOSES ALK5/SMAD3 SIGNALING AND
EXPRESSION OF EXTRACELLULAR MATRIX
COMPONENTS IN HUMAN CHONDROCYTES
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Purpose: Transforming growth factor-β (TGF-β) is a multifunc-
tional regulator of chondrocyte proliferation, differentiation and
extracellular matrix production. Dysregulation of TGF-β action
has been implicated in cartilage diseases such as osteoarthritis.
TGF-β signaling is transduced through a pair of transmembrane
serine/threonine kinases, known as the type I (ALK5) and type
II (TβRII) receptors. Activation of ALK5 leads to phosphoryla-
tion of intracellular Smad2 and Smad3, which associate with
the common Smad4 and then translocate to the nucleus where
they interact with coactivators and/or corepressors to modulate
expression of target genes in a cell-speciﬁc manner. However,
recent studies on endothelial cells have identiﬁed another TGF-β
type I receptor named ALK1, and its activation does not lead
to phosphorylation of Smad2 or Smad3, but instead leads to
phosphorylation of Smad1, 5 and 8. The goal of this study
was to determine if ALK1 is expressed in human chondrocytes
and to characterize its role in regulation of TGF-β signaling and
responses in human chondrocytes.
Methods: ALK1 mRNA and protein expression in human chon-
drocytes were examined by RT-PCR and Western blotting. The
interaction of ALK1 with other TGF-β receptor components was
studies by (1) [125I]TGF-β1 afﬁnity labeling of cell surface recep-
tors followed by immunoprecipitation with TGF-β receptor spe-
ciﬁc antibodies and (2) immunoprecipitation of unlabeled TGF-β
receptors followed by Western blotting using an anti-HA anti-
body to detect exogenously expressed ALK1-HA. The functional
role of ALK1 in regulation of TGF-β1-induced signaling and re-
sponses was examined by gain and loss of function studies.
Human chondrocytes overexpressing ALK1 or in which endoge-
nous ALK1 levels were reduced by ALK1 siRNA knockdown
were examined for their responsiveness to TGF-β1 by measuring
transcriptional activity (3TP-lux), Smad3-speciﬁc transcriptional
activity (CAGA12-lux), Smad1/5 and Smad3 phosphorylation and
expression levels of extracellular matrix components (type II
collagen, PAI-1 and ﬁbronectin).
Results: ALK1 mRNA and protein expression were demon-
strated in human chondrocytes. ALK1 was shown to be a com-
ponent of the TGF-β receptor system in human chondrocytes,
as evidenced by its interaction with ALK5, TβRII, endoglin and
betaglycan in the presence or absence of TGF-β1 ligand. Our
results indicate that both ALK1 and ALK5 are required for TGF-
β-induced phosphorylation of Smad1/5 whereas only ALK5 is
essential for TGF-β1-induced phosphorylation of Smad3 in these
cells. In addition, our results demonstrate that ALK1 inhibits,
while ALK5 potentiates, TGF-β-induced Smad3-driven transcrip-
tional activity and the expression of PAI-1, ﬁbronectin and type II
collagen.
Conclusions: Our results suggest that, in human chondrocytes,
TGF-β signals through two TGF-β type I receptors: ALK1 and
ALK5. Activation of the ALK5 pathway leads to activation of the
Smad3 pathway and increased expression of extracellular matrix
components, PAI-1, ﬁbronectin and type II collagen, whereas
activation of the ALK1 pathway opposes these functions. Our
study suggests that ALK1 plays an essential role in the regulation
of TGF-β signaling and function in the human cartilage.
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Purpose: The serine protease HtrA1 (also referred to as
PRSS11) has been shown to be one of the most abundant
proteases in cartilage, wherein its levels are upregulated during
osteoarthritis (OA). A hexapeptide derived from the C-terminus
of procollagen type II (and type III), designated CPII, has previ-
ously been shown to stimulate HtrA1 protease activity by tightly
interacting with its PDZ domain. The purpose of this study was
to investigate HtrA1-mediated cleavage of aggrecan and the ag-
onistic effect of CPII on HtrA1 activity, and to better understand
the role of HtrA1 in OA disease progression.
Methods: Identiﬁcation of potential HtrA1 substrates: Wildtype
HtrA1 (amino acids 157-480) and an inactive HtrA1 mutant
(S328A) were overexpressed in 3-D alginate cultures of primary
human chondrocytes. A mass spectrometry-based method was
utilized to identify potential HtrA1-generated cleavage products
released into the culture medium. In vitro cleavage of aggrecan:
Puriﬁed human aggrecan and recombinant aggrecan constructs
comprising either the G1-interglobular domain (IGD)-G2 or IGD
alone were incubated with puriﬁed recombinant HtrA1 (aa 157-
480) or an inactive HtrA1 mutant (aa 157-480, S328A). A control
peptide or CPII was added to the reactions to evaluate potential
